The tumour PKM2 dimer exhibits inhibited PKM2 enzyme activity, shunting glycolytic intermediaries towards anabolic processes to support rapid cell proliferation by a process that can be induced by Src phosphorylation of PKM2 [92, 93]. The gene discussed is PKM; the disease is neoplasm.